Platform venture capital is disrupting the nature of financing. Brad Joffe 17 August, 2017

Size: px

Start display at page:

Download "Platform venture capital is disrupting the nature of financing. Brad Joffe 17 August, 2017"

Alban Green
5 years ago
Views:

1 Platform venture capital is disrupting the nature of financing Brad Joffe 17 August, 2017

negotiating terms and providing ongoing portfolio management Unprecedented global connectivity driven by corporate partners and

2 OurCrowd sinnovative platform Leading global marketplace for corporates, institutions and investors (family offices, UHNW and HNW) to access, invest in and contribute as a group to building high quality technology start-ups Undertaking rigorous due diligence, negotiating terms and providing ongoing portfolio management Unprecedented global connectivity driven by corporate partners and limited partner base Robust portfolio centered around deep-tech such as big data, cyber-security, AI and machine learning, IoT and digital health 2

3 1. Global VC with over half the investments in Israel, why? 2. Crowdfunding and our approach to investment 3. OurCrowd s portfolio snapshot 4. OurCrowd team 3

4 Why Israel? #1 startup ecosystem outside of the US since 2012 #1 in R&D spend per capita globally Highest startup density in the world: 1 startup per 1000 inhabitants Attracts more foreign capital than any other EMEA ecosystem 3x more in exits ($75B) than invested ($25B) from 1000 exits Israel Ranks in sector: #1 in the world in medical device patents #1 in the world in scientific research institutions 4

5 Israeli venture defying global trends was a record year for Israel: $4.8B invested, 120% higher vs due to be another record year, with $2.8B invested in H Hundreds of Millions of $ Israeli VCs Foreign investors

Israel s exits in 2016 Israeli high-tech and startup

34x ** (5% above the 2015 figure) 27% of M&A deals involved

acquired sides *Zysman Aharoni, Gayer & Co.

6 Israel s exits in 2016 Israeli high-tech and startup companies were sold for $10+ billion Israeli companies raise record $4.8B * M&A Exits: $212M, Sony Average exits multiple: 4.34x ** (5% above the 2015 figure) 27% of M&A deals involved Israeli high-tech companies on both the acquiring and acquired sides *Zysman Aharoni, Gayer & Co. law firm survey **IVC-Meitar High-Tech Exits Report 2016 $4.4B, Giant Interactive Israel s biggest M&A since NDS was acquired in 2012 $430M, Oracle $320M, Cisco

Mobileye acquisition: A strong start to 2017 Mobileye s $15bn acquisition shows Israeli tech trending towards bigger ticket sizes and stronger exits On March 13 th, Intel announced its

7 Mobileye acquisition: A strong start to 2017 Mobileye s $15bn acquisition shows Israeli tech trending towards bigger ticket sizes and stronger exits On March 13 th, Intel announced its acquisition of Mobileye, the automotive sensor company, for $15.3B Largest acquisition exit in Israeli history Intel s autonomous driving division will now be based in Israel $15.3B, Intel 7

8 Who else is active in Israel? Between 2005 and 2017, these companies all bought at least one Israeli start-up 8

9 1. Global VC with over half the investments in Israel, why? 2. Crowdfunding and our approach to investment 3. OurCrowd s portfolio snapshot 4. OurCrowd team 9

10 A case for private market investing 10

A hybrid of venture capital and angel/crowd investing A simple model for quality investing: Highly selective deal flow: OurCrowd s team of investment professionals sees 150-200 new opportunities

11 A hybrid of venture capital and angel/crowd investing A simple model for quality investing: Highly selective deal flow: OurCrowd s team of investment professionals sees new opportunities every month, meets management teams, conducts in depth due diligence, then selects on average 2-3 companies to invest in. Access exclusive investment rounds: Through its extensive network, OurCrowd pursues top tier companies in which to invest and gains access to selective investment rounds. Full transparency: OurCrowd invests its own capital in every portfolio company alongside its investor community and provides the same terms as institutional co-investors in the round. 11

Index Fund Ultra-diversified fifty-company portfolio Our Innovation Fund Investing in the Australian

12 OurCrowd products Select your own Browse and select your own startup investments Portfolio Reserve VIP account with guaranteed allocation OurCrowd First Israel s premier seed-stage venture fund Funds OurCrowd Portfolio Index Fund Ultra-diversified fifty-company portfolio Our Innovation Fund Investing in the Australian innovation ecosystem OurCrowd Maniv Autonomous driving and mobility fund OurCrowd Qure Israel s first digital health fund 12

13 OurCrowd s platform Curated platform Detailed information memorandum and other materials Full terms of investment published including pricing Ongoing reporting 13

OurCrowd s point of difference Most active VC in Israel Professional,

curated deal flow and optionality Global scope, Israel focus Unrivaled Access

organisations Leveraging the wisdom of our 20,000 - strong crowd Key player

14 OurCrowd s point of difference Most active VC in Israel Professional, cross-sector investment team of over 30 investment professionals Fully curated deal flow and optionality Global scope, Israel focus Unrivaled Access to Innovation Across all stages and sectors Trusted partner of major global organisations Leveraging the wisdom of our 20,000 - strong crowd Key player in the Israeli ecosystem: access to the highest levels of business, tech, academia & govt. 14

15 Sourcing and selection OurCrowd employs a structured and efficient due diligence process focussed on selecting the highest value investment opportunities Typical Monthly Screening Process Key Diligence Criteria 200 potential deals per month 200 Screening by investment team 40+ Great Team and ability to execute Large Addressable Market Management meetings 20+ Can we add value? Deep Technology Ongoing in-depth diligence Prep Price sensitive Traction (series A onwards) Term sheet signed for investment and capital raising 15

16 Co-investment Partners 16

17 Building a real community & ecosystem OurCrowd provides dedicated support to assist portfolio companies in achieving growth objectives How OurCrowd supports its portfolio Selected partner companies Power of the crowd : investors assist companies with biz dev & networking via OC platform Strategic relationships: MNCs, VCs Industry expert mentor network Board Director / Observer for 70+% of portfolio Portfolio-wide services (e.g. CXO, HR, workshops) 17

19 1. Global VC with over half the investments in Israel, why? 2. Crowdfunding and our approach to investment 3. OurCrowd s portfolio snapshot 4. OurCrowd team 19

20 Our portfolio Stage and sector diverse 20

21 21

22 Consumer Physics (SCiO) Miniaturized spectrometer, allowing for the first hand-held molecular sensor. Applications: measuring nutritional information in foods, allergens, authenticating precious metals and leathers, etc. 22

23 ReWalk Robotics: giving paraplegics the power to stand up and walk ReWalk s robotic exoskeleton is being used by the VA in the USA and by hundreds of private patients the world over to regain mobility and quality of life following paralysis. RWLK

24 Zebra Medical: Driving the cost of medical diagnostics to zero Zebra is using machine learning to build software that can augment and replace human radiologists. They are pushing towards a vision where patients know everything possible to know immediately and at zero cost.

Biometric monitoring to catch fraud online Identifies fraudsters by analyzing

Each of us has a unique input style that creates a signature BioCatch checks

Securing our data in some of the biggest global banks Analysis of individual

25 Biometric monitoring to catch fraud online Identifies fraudsters by analyzing mouse/keyboard/touchscreen inputs. Each of us has a unique input style that creates a signature BioCatch checks unknown users against. Securing our data in some of the biggest global banks Analysis of individual mouse/touch microbehaviors WINNER-GLOBAL FINTECH AWARD SINGAPORE NOV 2016 NAT WEST SAYS: the breadth of behavioural biometrics that BioCatch technology can monitor is really impressive 25

26 1. Global VC with over half the investments in Israel, why? 2. Crowdfunding and our approach to investment 3. OurCrowd s portfolio snapshot 4. OurCrowd team 26

OurCrowd founders Jon Medved Co-Founder and CEO Serial entrepreneur

than USD $100M Founder and General Partner of Israel Seed Partners (USD

capitalists Washington Post Steven Blumgart Co-Founder Co-director of

Glencore 1998-2012 Co-director of the aluminum division at Glencore

27 OurCrowd founders Jon Medved Co-Founder and CEO Serial entrepreneur Co-founder and former CEO of Vringo 20 portfolio company exits greater than USD $100M Founder and General Partner of Israel Seed Partners (USD $260M Venture Capital Fund) One of Israel s leading high tech venture capitalists Washington Post Steven Blumgart Co-Founder Co-director of Glencore's aluminum division Senior executive, management committee at Glencore Co-director of the aluminum division at Glencore International plc, one of the largest commodity trading firms in the world, valued at $40bn. 27

Select OurCrowd team members OurCrowd is supported by individuals with significant experience in tech and venture investing (100+ ppl) Geoff Levy AO Global Chair of OurCrowd Board Co-founder and

Hollingdale & Page (now HSF) Held a number of non-executive directorships of ASX listed companies and Federal Government entities Alec Ellison Advisory Board Member 5+ years as Vice Chairman of

banking covering technology companies Morgan Stanley, Broadview International (President), Jefferies B.A.

head of their Israel practice 5 years in China as Head of Asia for William Blair 2 years in London as Managing Director of EMEA Tech Dan Bennett Partner & Managing Director, Australia & Asia 15 years

28 Select OurCrowd team members OurCrowd is supported by individuals with significant experience in tech and venture investing (100+ ppl) Geoff Levy AO Global Chair of OurCrowd Board Co-founder and Chairman of Monash Private Capital Former CEO and Executive Chairman of Investec Bank (Australia) Limited Non-executive Chairman of Cromwell Property Group Limited Former Partner with Freehill Hollingdale & Page (now HSF) Held a number of non-executive directorships of ASX listed companies and Federal Government entities Alec Ellison Advisory Board Member 5+ years as Vice Chairman of Jefferies where he held various positions in addition to leading the Tech group including Co-head of Investment banking and serving 7 years on the firm-wide Executive Committee 30 years in investment banking covering technology companies Morgan Stanley, Broadview International (President), Jefferies B.A. from Yale (summa cum laude) and MBA from Harvard Andy Kaye President and Chief Institutional Officer 21 years experience in finance around the globe 7 years at Robert Stephens where he was CEO and head of their Israel practice 5 years in China as Head of Asia for William Blair 2 years in London as Managing Director of EMEA Tech Dan Bennett Partner & Managing Director, Australia & Asia 15 years in corporate finance, venture capital and law Former Aust. General Counsel Babcock & Brown fund Structuring financial products in $13B investment house in Mayfair, London B Com (Finance) and Law UNSW, Australia Laly David Partner, Business Development Senior Bus. Dev across multiple disciplines and industries Focus on network effect for the portfolio Lawyer Mergers and Acquisitions (public and private): Willkie Farr & Gallagher David Shein Australian Director Founder and Managing Director of Dimension Data Pty Ltd (sold for over $1bn in 2000) Executive Chaiman and Founding Investor of Macromatix Non-Executive Chairman of Montech Holdings Limited Serial early stage investor & mentor 28

29 Legal Disclaimer The information contained in this presentation is intended to be general background information on OurCrowd and its activities. The information contained in this presentation is provided solely for informational purposes and does not constitute an invitation or offer of investment in any OurCrowd limited partnership related to any companies. This presentation does not constitute investment or financial product advice (nor tax, accounting or legal advice) or any recommendation to acquire any interests in any OurCrowd limited partnership related to any companies. Anything contained in this presentation should not be construed as creating a presumption by you or OurCrowd that you are a sophisticated investor. The offer to invest in any OurCrowd limited partnership related to any company can only be made on the OurCrowd website and only to investors who have been fully qualified as sophisticated investors in accordance with the laws and regulations of their respective jurisdictions. OurCrowd makes no representation or warranty, express or implied, with respect to any data provided to you regarding any information provided by the companies on its web site or in this presentation and will not be liable in any way to you or to any other person for any inaccuracy, error or omission (including without limitation, where caused by third parties) of any suchdata or information. OurCrowd does not accept responsibility or liability for any loss or damage suffered or incurred by you or any other person or entity however caused relating in any way to this presentation. Please be aware that investments in early stage companies contains a high level of risk and you should consider this prior to making any investment decisions. 29

Israel Venture Capital Investments Report Q3 2017

Israel Venture Capital Investments Report Q3 2017 NOVEMBER 2017 Summary of Israeli Venture Capital Raising Q3/2017 +14% from Q2/2017 Israeli high-tech capital raising summed up to $1.44B @ ALL RIGHTS RESERVED.